| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | $11.0B |
| Cost of Revenue | $39.1B | $38.0B | $36.1B | $34.7B | $24.5B | $29.8B | $27.8B | — |
| Gross Profit | — | — | — | — | $3.1B | $3.5B | $3.1B | $3.1B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $10.9B | $10.5B | $8.9B | $9.1B | $7.0B | $7.5B | $6.9B | $6.4B |
| Operating Income | — | — | — | — | — | — | $4.8B | $4.4B |
| Net Income | $4.9B | $4.5B | $3.5B | $3.3B | $0.3B | $1.0B | $0.8B | $0.9B |
| EPS (Basic) | $4.31 | $3.90 | $3.00 | $2.74 | $0.27 | $0.82 | $0.69 | $1.39 |
| EPS (Diluted) | $4.26 | $3.86 | $2.97 | $2.70 | $0.27 | $0.81 | $0.68 | $1.37 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $31.7B | $29.7B | $28.3B | $28.5B | $30.8B | $24.1B | $14.3B | $14.1B |
| Current Assets | $13.0B | $12.7B | $12.5B | $13.3B | $15.7B | $8.9B | $8.5B | $8.5B |
| Cash & Equivalents | $5.3B | $5.6B | $5.5B | $6.2B | $10.5B | $3.2B | $3.0B | $2.8B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $11.0B | $10.5B | $10.3B | $10.5B | $10.8B | $7.2B | $5.5B | $5.1B |
| Stockholders' Equity | $8.4B | $7.3B | $6.4B | $6.0B | $5.8B | $5.9B | $5.0B | $5.1B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.1B | $6.1B | $4.1B | $3.1B | $4.6B | $4.1B | $4.1B | — |
| Investing Cash Flow | $-2.5B | $-1.7B | $-1.5B | $-1.0B | $-0.6B | $-1.5B | $-0.6B | — |
| Capital Expenditures | $1.9B | $1.7B | $1.5B | $1.0B | $0.6B | $1.2B | $1.1B | $1.1B |
| Financing Cash Flow | $-3.8B | $-4.2B | $-3.3B | $-6.2B | $3.2B | $-2.4B | $-3.1B | — |